Buffalo, NY, December 11, 2025 Today, Tom McMahon, CUBRC President and CEO announced that CUBRC’s wholly owned subsidiary Avarint, LLC was awarded a sole-source, $96M indefinite-delivery/indefinite-quantity (IDIQ) type contract by…
Read More
Recent Posts
- Avarint Awarded $96M Contract for the Continued Development and Support of Advanced Modeling and Simulation Capabilities for the U.S. Air Force
- CUBRC and EpiVax Awarded FDA Contract worth $2 Million for Development of Control Peptides for Immunogenicity Risk Assessment Assays Supporting Regulatory Filings of Generic Peptide Drugs
- CUBRC Acquires Ahmic Aerospace
- CUBRC Participates in First-of-its-kind Air Force Office of Scientific Research (AFOSR) Hypersonic Sounding Rocket BOLT II Flight Program
- Continuing A Long History of Support for Defense Industry in WNY, Schumer Announces $16 Million From DOD for Buffalo-Based CUBRC; Senator Says Funding Will Boost World-Class Organization and WNY Economy
